Editors' ChoiceCancer

Targeting leukemia-specific mutations

See allHide authors and affiliations

Science Translational Medicine  09 Sep 2020:
Vol. 12, Issue 560, eabe1713
DOI: 10.1126/scitranslmed.abe1713

Abstract

T cells can recognize neoantigens derived from protein products of characteristic genetic fusions and thereby specifically target leukemia cells.

View Full Text

Stay Connected to Science Translational Medicine